potassium phosphates

Generic: potassium phosphates

Labeler: cipla usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name potassium phosphates
Generic Name potassium phosphates
Labeler cipla usa inc.
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

dibasic potassium phosphate 236 mg/mL, monobasic potassium phosphate 224 mg/mL

Manufacturer
Cipla USA Inc.

Identifiers & Regulatory

Product NDC 69097-055
Product ID 69097-055_2f2fccc5-9cbf-27d6-e063-6294a90a55f9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217892
Listing Expiration 2026-12-31
Marketing Start 2025-02-06

Pharmacologic Class

Classes
increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] osmotic activity [moa] osmotic laxative [epc] potassium compounds [cs] potassium salt [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69097055
Hyphenated Format 69097-055

Supplemental Identifiers

RxCUI
1928567 1928569 2667657
UNII
4J9FJ0HL51 CI71S98N1Z

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name potassium phosphates (source: ndc)
Generic Name potassium phosphates (source: ndc)
Application Number ANDA217892 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 236 mg/mL
  • 224 mg/mL
source: ndc
Packaging
  • 25 VIAL in 1 CARTON (69097-055-97) / 50 mL in 1 VIAL (69097-055-67)
source: ndc

Packages (1)

69097-055-97 25 VIAL in 1 CARTON (69097-055-97) / 50 mL in 1 VIAL (69097-055-67)

Ingredients (2)

dibasic potassium phosphate (236 mg/mL) monobasic potassium phosphate (224 mg/mL)

Linked Drug Pages (1)

Potassium Phosphates ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "2f2fccc5-9cbf-27d6-e063-6294a90a55f9", "openfda": {"unii": ["4J9FJ0HL51", "CI71S98N1Z"], "rxcui": ["1928567", "1928569", "2667657"], "spl_set_id": ["f1f26a17-d2e2-48f5-9054-8ee7e380556e"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (69097-055-97)  / 50 mL in 1 VIAL (69097-055-67)", "package_ndc": "69097-055-97", "marketing_start_date": "20250206"}], "brand_name": "Potassium Phosphates", "product_id": "69097-055_2f2fccc5-9cbf-27d6-e063-6294a90a55f9", "dosage_form": "INJECTION", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Potassium Compounds [CS]", "Potassium Compounds [CS]", "Potassium Salt [EPC]", "Potassium Salt [EPC]"], "product_ndc": "69097-055", "generic_name": "Potassium Phosphates", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Potassium Phosphates", "active_ingredients": [{"name": "DIBASIC POTASSIUM PHOSPHATE", "strength": "236 mg/mL"}, {"name": "MONOBASIC POTASSIUM PHOSPHATE", "strength": "224 mg/mL"}], "application_number": "ANDA217892", "marketing_category": "ANDA", "marketing_start_date": "20250206", "listing_expiration_date": "20261231"}